Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani, Brian C. Shaffer, Nirav N. Shah, Alisha Mussetter, Xiao-Ying Tang, John M. McCarty, Asif Alavi, Nosha Farhadfar, Katarzyna Jamieson, Nancy M. Hardy, Hannah Choe, Richard F. Ambinder, Claudio Anasetti, Miguel‐Angel Perales, Stephen R. Spellman, Alan Howard, Krishna V. Komanduri, Leo Luznik, Maxim Norkin, Joseph A. Pidala, Voravit Ratanatharathorn, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Javier Bolaños‐Meade
Topics & Concepts
MedicineCyclophosphamideInternal medicineTransplantationIncidence (geometry)Bone marrowClinical trialProspective cohort studyClinical endpointSurgeryHematopoietic stem cell transplantationHematopoietic cellGastroenterologyOncologyChemotherapyHaematopoiesisStem cellOpticsBiologyPhysicsGeneticsHematopoietic Stem Cell TransplantationT-cell and B-cell Immunology